Table 2.

Grade III-IV toxicities with lenalidomide as monotherapy in relapsed/refractory DLBCL.

	NHL002 [52]	NHL003 [53]
	%	%
Neutropenia	33	41
Febrile neutropenia	6.1	2.3
Thrombocytopenia	20.4	18.4
Anemia	6.1	9.2
Fatigue	6.1	4.6
Deep vein thrombosis	2	2.3
Neuropathy	0	0